Literature DB >> 24284476

The flavonoid apigenin delays forgetting of passive avoidance conditioning in rats.

Miroljub Popović1, María Caballero-Bleda, Obdulio Benavente-García, Julián Castillo.   

Abstract

The present experiments were performed to study the effect of the flavonoid apigenin (20 mg/kg intraperitoneally (i.p.), 1 h before acquisition), on 24 h retention performance and forgetting of a step-through passive avoidance task, in young male Wistar rats. There were no differences between saline- and apigenin-treated groups in the 24 h retention trial. Furthermore, apigenin did not prevent the amnesia induced by scopolamine (1mg/kg, i.p., 30 min before the acquisition). The saline- and apigenin-treated rats that did not step through into the dark compartment during the cut-off time (540 s) were retested weekly for up to eight weeks. In the saline treated group, the first significant decline in passive avoidance response was observed at four weeks, and complete memory loss was found five weeks after the acquisition of the passive avoidance task. At the end of the experimental period, 60% of the animals treated with apigenin still did not step through. These data suggest that 1) apigenin delays the long-term forgetting but did not modulate the 24 h retention of fear memory and 2) the obtained beneficial effect of apigenin on the passive avoidance conditioning is mediated by mechanisms that do not implicate its action on the muscarinic cholinergic system.

Entities:  

Keywords:  Apigenin; flavonoids; forgetting; memory retention; passive avoidance; scopolamine

Mesh:

Substances:

Year:  2013        PMID: 24284476     DOI: 10.1177/0269881113512040

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  6 in total

Review 1.  Pharmacological considerations for treating neuroinflammation with curcumin in Alzheimer's disease.

Authors:  Xian Zhou; Madhuri Venigalla; Ritesh Raju; Gerald Münch
Journal:  J Neural Transm (Vienna)       Date:  2022-03-16       Impact factor: 3.850

Review 2.  Curcumin and Apigenin - novel and promising therapeutics against chronic neuroinflammation in Alzheimer's disease.

Authors:  Madhuri Venigalla; Erika Gyengesi; Gerald Münch
Journal:  Neural Regen Res       Date:  2015-08       Impact factor: 5.135

3.  Neuroprotective Effects of Açaí (Euterpe oleracea Mart.) against Rotenone In Vitro Exposure.

Authors:  Alencar Kolinski Machado; Ana Cristina Andreazza; Tatiane Morgana da Silva; Aline Augusti Boligon; Vanusa do Nascimento; Gustavo Scola; Angela Duong; Francine Carla Cadoná; Euler Esteves Ribeiro; Ivana Beatrice Mânica da Cruz
Journal:  Oxid Med Cell Longev       Date:  2016-10-03       Impact factor: 6.543

4.  Compound Schisandra-Ginseng-Notoginseng-Lycium Extract Ameliorates Scopolamine-Induced Learning and Memory Disorders in Mice.

Authors:  Ning Li; Cong Liu; Shu Jing; Mengyang Wang; Han Wang; Jinghui Sun; Chunmei Wang; Jianguang Chen; He Li
Journal:  Evid Based Complement Alternat Med       Date:  2017-07-26       Impact factor: 2.629

Review 5.  Neurodegenerative Diseases: Might Citrus Flavonoids Play a Protective Role?

Authors:  Santa Cirmi; Nadia Ferlazzo; Giovanni E Lombardo; Elvira Ventura-Spagnolo; Sebastiano Gangemi; Gioacchino Calapai; Michele Navarra
Journal:  Molecules       Date:  2016-09-30       Impact factor: 4.411

6.  Histological and imunohistochemical alterations of hippocampus and prefrontal cortex in a rat model of Alzheimer like-disease with a preferential role of the flavonoid "hesperidin".

Authors:  Dalia A Mandour; M A Bendary; Amira E Alsemeh
Journal:  J Mol Histol       Date:  2021-06-25       Impact factor: 2.611

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.